392 related articles for article (PubMed ID: 29421274)
1. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
2. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.
Marathe BM; Prislovsky A; Astrakhan A; Rawlings DJ; Wan JY; Strom TS
Exp Hematol; 2009 Nov; 37(11):1353-63. PubMed ID: 19733207
[TBL] [Abstract][Full Text] [Related]
4. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
5. WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.
Shcherbina A; Cooley J; Lutskiy MI; Benarafa C; Gilbert GE; Remold-O'Donnell E
Br J Haematol; 2010 Feb; 148(3):416-27. PubMed ID: 19863535
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
7. Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.
Prislovsky A; Marathe B; Hosni A; Bolen AL; Nimmerjahn F; Jackson CW; Weiman D; Strom TS
Exp Hematol; 2008 May; 36(5):609-23. PubMed ID: 18346836
[TBL] [Abstract][Full Text] [Related]
8. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
9. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
[TBL] [Abstract][Full Text] [Related]
10. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
Shcherbina A; Rosen FS; Remold-O'Donnell E
J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
[TBL] [Abstract][Full Text] [Related]
11. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
[TBL] [Abstract][Full Text] [Related]
12. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
[TBL] [Abstract][Full Text] [Related]
13. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
[TBL] [Abstract][Full Text] [Related]
14. Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis.
Prislovsky A; Zeng X; Sokolic RA; Garabedian EN; Anur P; Candotti F; Strom TS
Platelets; 2013; 24(4):288-96. PubMed ID: 22812495
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
[TBL] [Abstract][Full Text] [Related]
16. N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Volpi S; Santori E; Abernethy K; Mizui M; Dahlberg CI; Recher M; Capuder K; Csizmadia E; Ryan D; Mathew D; Tsokos GC; Snapper S; Westerberg LS; Thrasher AJ; Candotti F; Notarangelo LD
Blood; 2016 Jan; 127(2):216-20. PubMed ID: 26468226
[TBL] [Abstract][Full Text] [Related]
17. Platelets in Wiskott-Aldrich syndrome: Victims or executioners?
Sereni L; Castiello MC; Villa A
J Leukoc Biol; 2018 Mar; 103(3):577-590. PubMed ID: 28851742
[TBL] [Abstract][Full Text] [Related]
18. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.
Snapper SB; Rosen FS; Mizoguchi E; Cohen P; Khan W; Liu CH; Hagemann TL; Kwan SP; Ferrini R; Davidson L; Bhan AK; Alt FW
Immunity; 1998 Jul; 9(1):81-91. PubMed ID: 9697838
[TBL] [Abstract][Full Text] [Related]
19. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
[TBL] [Abstract][Full Text] [Related]
20. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
